Weaver Dale, Pershing Michelle L, Golden Bethany, Hammel Laura, Russ Pauline Kefalas, Cripe Mark
OhioHealth Cancer Care, 3535 Olentangy River Road Columbus, Columbus, OH, 43214, USA.
OhioHealth Research Institute, 3545 Olentangy River Road Columbus, Columbus, OH, 43214, USA.
Support Care Cancer. 2024 Mar 13;32(4):225. doi: 10.1007/s00520-024-08393-7.
Scalp cooling is an increasingly recognized non-pharmacologic approach to minimize chemotherapy-induced alopecia (CIA). Several commercially available machine-based and manual scalp cooling systems are available; however, literature reports of effectiveness are highly variable. The purpose of this study was to determine real-world tolerability and subjective effectiveness of a manual cold capping system in minimizing CIA across a variety of patient race and hair types. This study was a single-institution review of outcomes from manual cold capping.
We identified retrospective cohort of adult patients who presented to discuss cold capping between January 14, 2019, and March 31, 2022. Data collected from medical records included demographics, decision to pursue/continue cold capping, diagnoses, chemotherapy regimens, hair characteristics (length, thickness, coarseness, type), and subjective perception of percentage of hair retained. Those with successful vs. unsuccessful cold capping (≥ 50% vs. < 50% of hair retained) were compared based on the patient-level factors of interest.
A total of 100 patients initiated cold capping during the study period, and 95% of them completed cold capping. The majority of patients who started cold capping completed it. The median-reported percentage of hair maintained was 75%, and 82/89 (92.1% of patients) had favorable results, defined as ≥ 50% of hair retained. The only patient-level factor associated with favorable response was chemotherapy regimen, with fewer patients receiving doxorubicin-containing regimens having successful hair retention compared to other chemotherapy types (71.4% successful results vs. 95.7% for those receiving paclitaxel-containing regimens and 96.6% for those receiving docetaxel-containing regimens (p = 0.018). There was no difference in success based on patient race/ethnicity or hair characteristics.
The overall effectiveness (92.1%) in this study is consistent to higher than many literature reports. One possible reason for the high success in our cohort is compliance with cold capping protocols, meaning applying the cap in the appropriate manner and wearing the cap for the prescribed durations, which may impact effectiveness.
头皮冷却作为一种日益被认可的非药物方法,可将化疗引起的脱发(CIA)降至最低。目前有几种市售的基于机器和手动的头皮冷却系统;然而,关于其有效性的文献报道差异很大。本研究的目的是确定手动冷帽系统在不同种族和发型的患者中减少CIA的实际耐受性和主观有效性。本研究是对手动冷帽结果的单机构回顾。
我们确定了2019年1月14日至2022年3月31日期间前来讨论冷帽的成年患者的回顾性队列。从医疗记录中收集的数据包括人口统计学、决定采用/继续冷帽、诊断、化疗方案、头发特征(长度、厚度、粗糙度、类型)以及对保留头发百分比的主观感受。根据感兴趣的患者层面因素,比较冷帽成功与失败(头发保留≥50%与<50%)的患者。
在研究期间,共有100名患者开始使用冷帽,其中95%完成了冷帽治疗。大多数开始使用冷帽的患者完成了治疗。报告的头发保留中位数百分比为75%,82/89(92.1%的患者)取得了良好效果,定义为头发保留≥50%。与良好反应相关的唯一患者层面因素是化疗方案,与其他化疗类型相比,接受含阿霉素方案的患者成功保留头发的较少(成功结果为71.4%,接受含紫杉醇方案的患者为95.7%,接受含多西他赛方案的患者为96.6%(p = 0.018)。基于患者种族/民族或头发特征的成功率没有差异。
本研究中的总体有效性(92.1%)与许多文献报道一致或更高。我们队列中高成功率的一个可能原因是遵守冷帽方案,即以适当方式佩戴冷帽并按规定时间佩戴,这可能会影响有效性。